oneplacenewsSource: ScienceDaily Health
Summary
A clinical trial is investigating the potential of high doses of vitamin B3 in improving outcomes for glioblastoma patients. Early results suggest that niacin may enhance immune response against the aggressive brain cancer, leading to better progression-free survival rates.
Why It Matters
This research could revolutionize treatment strategies for glioblastoma, one of the deadliest brain cancers with limited effective therapies. By harnessing the power of vitamin B3 to rejuvenate immune cells, it may provide a new, accessible option for patients, potentially improving survival rates and quality of life.
